首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1672748

成人疫苗市場：依疫苗、疫苗類型、技術和地區分類

Adult Vaccines Market, By Vaccines, By Vaccine Type, By Technology, By Geography

出版日期: 2025年02月13日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球成人疫苗市場規模估計為 196.6 億美元，預計到 2032 年將達到 350.5 億美元，2025 年至 2032 年的複合年成長率為 8.6%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	196.6億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	8.60%	2032 年價值預測	350.5億美元

數字。 2025 年成人疫苗市場佔有率（按地區）

全球成人疫苗市場的成長得益於政府和私人公司對成人疫苗接種計劃的投資增加。成人疫苗接種已變得流行，因為它們可以保護社會弱勢群體免受嚴重疾病和感染疾病。提高對現有疫苗及其對成年人益處的認知正在鼓勵更多的人接種疫苗。此外，現有成人疫苗適應症的擴大和新製劑的開發正在增強對全球成年人口中多種疾病的防護。然而，新興國家高昂的開發成本和缺乏足夠的疫苗接種基礎設施正在阻礙市場的發展。

市場動態：

全球成人疫苗市場的成長是由成人中流感、腦膜炎雙球菌性腦膜炎和肺炎鏈球菌感染等疾病的盛行率上升所推動的。根據世界衛生組織（WHO）統計，季節性流感每年在全球造成約300萬至500萬重症患者，29萬至65萬呼吸道疾病死亡。醫療保健支出的增加、政府透過疫苗接種計劃提供的優惠支持以及新疫苗的推出正在推動市場成長。然而，新興國家認知度較低、開發新疫苗相關的研發成本高以及儲存要求可能會阻礙市場成長。開發無需冷藏的耐熱疫苗和成人聯合疫苗可能提供市場機會。

本研究的主要特點

本報告對全球成人疫苗市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數涵蓋了全球成人疫苗市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球成人疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球成人疫苗市場的各種策略矩陣來做出決策。

公司簡介
- GlaxoSmithKline plc
- Merck &Co., Inc.
- Pfizer Inc.
- Sanofi Pasteur
- AstraZeneca
- Johnson &Johnson
- Novavax, Inc.
- Moderna, Inc.
- Inovio Pharmaceuticals, Inc.
- Bavarian Nordic
- Dynavax Technologies Corporation
- BioNTech S
- Emergent BioSolutions Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Sinovac Biotech Ltd.

第 10 章分析師建議

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1091

Global Adult Vaccines Market is estimated to be valued at USD 19.66 Bn in 2025 and is expected to reach USD 35.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 19.66 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 35.05 Bn

Figure. Adult Vaccines Market Share (%), By Region 2025

Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness about available vaccines and their benefits for adults has prompted more individuals to get vaccinated. Moreover, expansion of indications for existing adult vaccines and development of new formulations have strengthened prevention against various diseases affecting the adult population worldwide. However, high development costs and lack of adequate vaccination infrastructure in developing nations can hamper the market growth.

Market Dynamics:

Global adult vaccines market growth is driven by rising prevalence of diseases such as influenza, meningococcal meningitis, pneumococcal infection, and others among adults. According to the World Health Organization, seasonal influenza results in severe illness in around 3-5 million cases and 290,000-650,000 respiratory deaths globally every year. Increasing healthcare expenditures, favorable government support through vaccination programs and introduction of novel vaccines can drive the market growth. However, low awareness in developing countries, high R&D costs associated with development of new vaccines and storage requirements can hamper the market growth. Development of thermostable vaccines without refrigeration needs and combined adult vaccine formulations can offer opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Novavax, Pfizer, and CSL Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Detailed Segmentation-

By Vaccines
- Influenza
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Varicella
- Human Papillomavirus
- Zoster
- Measles, Mumps, Rubella (MMR)
- Pneumococcal
- Hepatitis
- Others
By Vaccine Type
- Monovalent
- Multivalent
By Technology
- Live Attenuated Vaccines
- Inactivated Viral/Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi Pasteur
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- Moderna, Inc.
- Inovio Pharmaceuticals, Inc.
- Bavarian Nordic
- Dynavax Technologies Corporation
- BioNTech S
- Emergent BioSolutions Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Sinovac Biotech Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccines
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Adult Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Adult Vaccines Market, By Vaccines, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Varicella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Human Papillomavirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Zoster
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Measles, Mumps, Rubella (MMR)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Adult Vaccines Market, By Vaccine Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monovalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multivalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Adult Vaccines Market, By Technology, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Live Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inactivated Viral/Bacterial Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Toxoid Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Conjugate Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Adult Vaccines Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi Pasteur
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novavax, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Moderna, Inc.
- Inovio Pharmaceuticals, Inc.
- Bavarian Nordic
- Dynavax Technologies Corporation
- BioNTech S
- Emergent BioSolutions Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Sinovac Biotech Ltd.